Will the next generation of CAR-T cells be modified using base editing?
Posted in Exclusive Content
| Tagged Analysis, Biologics / Biotechnology, Business, Cell therapy, Clinical trials, Drug development, Drug discovery, Drug targets, Enabling technologies, Gene editing, Gene therapy, Genetics / genomes, Immunology, In Silico Biology, Lead discovery, Protein chemistry / Proteomics, RNA, Stem cells, System biology, Systems biology, Therapeutics
